SP
BravenNow
🏢
🏢 Company

Lineage Cell Therapeutics

Clinical-stage biotechnology company developing novel cell therapies

📊 Rating

3 news mentions · 👍 0 likes · 👎 0 dislikes

💡 Information Card

# Lineage Cell Therapeutics


Who / What

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of innovative cell therapies to address critical unmet medical needs. The company leverages its proprietary platform and in-house capabilities for cell-based therapy research, manufacturing, and clinical advancement.


---


Background & History

Lineage Cell Therapeutics was established as a clinical-stage biotech focused on advancing novel cell therapies. While specific founding details are not widely documented, the company operates within the broader biotechnology sector, emphasizing its proprietary platform to drive therapeutic innovation in unmet medical areas. The company’s development and manufacturing capabilities are central to its mission.


---


Why Notable

Lineage Cell Therapeutics stands out for its pioneering approach to cell-based therapies, addressing significant gaps in medical treatment through its robust platform. Its focus on clinical-stage advancements positions it as a key player in the biotechnology industry, particularly in areas requiring novel therapeutic solutions. The company’s in-house development and manufacturing capabilities further distinguish it from competitors.


---


In the News

As of available data, Lineage Cell Therapeutics remains active in its clinical-stage research without recent high-profile news coverage. Its relevance lies in its ongoing contributions to advancing cell therapy innovations, positioning it as a potential leader in future medical breakthroughs within the biotech sector.


---

Key Facts


  • **Type:** Clinical-stage biotechnology company
  • **Also known as:** (No widely recognized alternative names or abbreviations documented)
  • **Founded / Born:** Year and specific founding details not publicly available; inferred from industry context.
  • **Key dates:**
  • Established within the clinical-stage biotech landscape (exact year unclear).
  • Focused on proprietary cell therapy platform development and manufacturing capabilities.
  • **Geography:** Operates primarily in the United States, with headquarters likely in a major biotechnology hub such as Boston or Cambridge, MA (specific location not confirmed).
  • **Affiliation:**
  • Independent clinical-stage biotech company.
  • Operates within the broader biotechnology industry focused on cell-based therapies.

  • ---

    Links

  • [Wikipedia](https://en.wikipedia.org/wiki/Lineage_Cell_Therapeutics)
  • Sources

    📌 Topics

    • SEC Filing (1)
    • Corporate Finance (1)
    • Corporate Governance (1)
    • Financial Disclosure (1)
    • Earnings Results (1)
    • Stock Performance (1)
    • Biotechnology Sector (1)

    🏷️ Keywords

    Lineage Cell Therapeutics (3) · Form S-3 (1) · SEC (1) · registration statement (1) · securities offering (1) · capital raising (1) · biotechnology (1) · Form 4 (1) · insider trading (1) · SEC filing (1) · March 6 (1) · corporate transparency (1) · stock transactions (1) · Earnings Beat (1) · Revenue Estimates (1) · LCTX Stock (1) · Financial Health (1) · Biotechnology (1) · EPS Revisions (1)

    📖 Key Information

    Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities.

    📰 Related News (3)

    🔗 Entity Intersection Graph

    SEC filing(1)SEC(1)Lineage Cell Therapeutics

    People and organizations frequently mentioned alongside Lineage Cell Therapeutics:

    🔗 External Links